Voloridge Investment Management’s Briacell Therapeutics BCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-101	Closed	-$154K	–	1425
2022 Q1	$154K	Sell	101 -1,255	-93%	-$1.91M	﹤0.01%	1308
2021 Q4	$1.68M	Buy	1,356 +310	+30%	+$385K	0.01%	1126
2021 Q3	$1.27M	Buy	+1,046	New	+$1.27M	0.01%	1205